1. Comprehensive analysis of mutations in the hepatitis delta virus genome based on full-length sequencing in a nationwide cohort study and evolutionary pattern during disease progression. (May 2015) Authors: Shirvani-Dastgerdi, E.; Amini-Bavil-Olyaee, S.; Alavian, S. Moayed; Trautwein, C.; Tacke, F. Journal: Clinical microbiology and infection Issue: Volume 21:Number 5(2015:May) Page Start: 510.e11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. CXCR5 is critically involved in progression of lupus through regulation of B cell and double‐negative T cell trafficking. (18th April 2016) Authors: Wiener, A.; Schippers, A.; Wagner, N.; Tacke, F.; Ostendorf, T.; Honke, N.; Tenbrock, K.; Ohl, K. Journal: Clinical and experimental immunology Issue: Volume 185:Number 1(2016:Jul.) Page Start: 22 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Hepatitis B e antigen‐suppressing mutations enhance the replication efficiency of adefovir‐resistant hepatitis B virus strains. Issue 2 (3rd July 2012) Authors: Herbers, U.; Amini‐Bavil‐Olyaee, S.; Mueller, A.; Luedde, T.; Trautwein, C.; Tacke, F. Journal: Journal of viral hepatitis Issue: Volume 20:Issue 2(2013) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Hepatitis delta virus facilitates the selection of hepatitis B virus mutants in vivo and functionally impacts on their replicative capacity in vitro. (January 2016) Authors: Shirvani-Dastgerdi, E.; Pourkarim, M.R.; Herbers, U.; Amini-Bavil-Olyaee, S.; Yagmur, E.; Alavian, S.M.; Trautwein, C.; Tacke, F. Journal: Clinical microbiology and infection Issue: Volume 22:Number 1(2016) Page Start: 98.e1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Results From Multicenter Sars-Cov-2 Antibody Prevalence Study In Patients With Short Bowel Syndrome In Germany. (April 2023) Authors: Blüthner, E.; Pape, U.-F.; Blumenstein, I.; Wichmann, J.; Tacke, F.; Moosburner, S. Journal: Clinical nutrition ESPEN Issue: Volume 54(2023) Page Start: 645 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Soluble urokinase plasminogen activator receptor is compartmentally regulated in decompensated cirrhosis and indicates immune activation and short‐term mortality. (17th March 2013) Authors: Zimmermann, H. W.; Reuken, P. A.; Koch, A.; Bartneck, M.; Adams, D. H.; Trautwein, C.; Stallmach, A.; Tacke, F.; Bruns, T. Journal: Journal of internal medicine Issue: Volume 274:Number 1(2013:Jul.) Page Start: 86 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Teduglutide therapy optimization through continuous oral nutrition counselling in chronic intestinal failure patients. (April 2023) Authors: Pape, U.-F.; Blüthner, E.; Thurmann, D.; Büttner, J.; Tacke, F.; Maasberg, S.; Pevny, S. Journal: Clinical nutrition ESPEN Issue: Volume 54(2023) Page Start: 708 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Teduglutide treatment for chronic intestinal failure patients in germany – insights from a patient home care service program. (December 2020) Authors: Pevny, S.; Wehkamp, J.; Fusco, S.; Zopf, Y.; Herrmann, H.J.; Lamprecht, G.; Jacob, T.; Schiefke, I.; von Websky, M.W.; Büttner, J.; Blüthner, E.; Tacke, F.; Pape, U.-F.; Maasberg, S. Journal: Clinical nutrition ESPEN Issue: Volume 40(2020) Page Start: 436 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗